Lumpy Skin Disease Virus ORF137 Protein Inhibits Type I Interferon Production by Interacting with and Decreasing the Phosphorylation of IRF3
Cells · 2025
DOI: 10.3390/cells14181475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Qunhua Ke und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-3, Viral Proteins, Interferon Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Gansu Province Science and Technology Foundation for Cooperation Program, the Basic Research Project of Yazhouwan National Laboratory, the Key Development and Research Foundation of Gansu.
Abstract (Originalsprache)
Lumpy skin disease (LSD) is an invasive infectious disease caused by the lumpy skin disease virus (LSDV), which is detrimental to the production of cattle. LSDV encodes about 156 proteins, most of whose functions are still unknown. In this study, we found that the ORF137 protein was identified as one of the strongest inhibitors of IFN-β and ISG expression, determining LSDV ORF137 as a negative regulator of interferon (IFN) β signaling. Further evidence suggests that ORF137 interacts with the signal transduction factor IRF3 and inhibits the activation of IFN-β signaling by reducing Phospho-IRF3 (p-IRF3). Further investigation indicated that overexpression of ORF137 in BMEC could significantly inhibit the transcription of IFN-β and ISGs, thereby promoting the replication of LSDV. More importantly, through homologous recombination, we deleted the ORF137 gene from the LSDV/FJ/CHA/2021 strain and constructed the recombinant strain LSDV-ΔORF137-EGFP. Compared with the parental strain, LSDV-ΔORF137-EGFP showed a weakened effect on inhibiting the transcription of IFN-β and ISGs and a reduced replication level in infected MDBK cells. In summary, ORF137 facilitates LSDV replication by targeting IRF3 to inhibit IFN-β signaling. Our findings reveal a new mechanism by which LSDV suppresses the host antiviral response, which may facilitate the development of attenuated live vaccines for LSDV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China.
- State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
- Yazhouwan National Laboratory, Sanya 572024, China.
ORCID-Profile: Qunhua Ke, Zhengji Liang
Förderung
- the Gansu Province Science and Technology Foundation for Cooperation Program
- the Basic Research Project of Yazhouwan National Laboratory
- the Key Development and Research Foundation of Gansu
- the National Natural Science Foundation of China (NSFC)
- Gansu Province Science and Technology Foundation for Cooperation Program
- Basic Research Project of Yazhouwan National Laboratory
- Key Development and Research Foundation of Gansu
Zitieren
APA
Ke, Q., Yao, K., Qu, M., Liang, Z., Li, M., Wang, X., Yin, X., & Sun, Y. (2025). Lumpy Skin Disease Virus ORF137 Protein Inhibits Type I Interferon Production by Interacting with and Decreasing the Phosphorylation of IRF3. Cells. https://doi.org/10.3390/cells14181475
Vancouver
Ke Q, Yao K, Qu M, Liang Z, Li M, Wang X, et al. Lumpy Skin Disease Virus ORF137 Protein Inhibits Type I Interferon Production by Interacting with and Decreasing the Phosphorylation of IRF3. Cells. 2025. doi:10.3390/cells14181475
BibTeX
@article{Ke2025,
author = {Ke, Qunhua and Yao, Kaishen and Qu, Min and Liang, Zhengji and Li, Miaomiao and Wang, Xiangwei and Yin, Xiangping and Sun, Yuefeng},
title = {Lumpy Skin Disease Virus ORF137 Protein Inhibits Type I Interferon Production by Interacting with and Decreasing the Phosphorylation of IRF3},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14181475}
}
EUVIMED